Skip to main content
. 2016 Nov 9;25(3):879–886. doi: 10.1007/s00520-016-3476-8

Table 2.

Summary table of the influence of functional status, frailty and comorbidity on the treatment decision-making process

Domains Older Adult Family member Cancer Specialist Family physician
Functional status Prolonging life is most important, for others maintaining quality of life is important Prolonging life is most important Most patients were fit, performance status is taken into account Not involved
Comorbidity Other health conditions do not play a role in the chemotherapy decision Other health conditions do not play a role in the chemotherapy decision Comorbidity is taken into account but most patients were fit so it did not play an important role Not contacted for the patient’s medical history, some feel the patient’s comorbidity is underappreciated by oncologists
Frailty Not mentioned by patients Not mentioned by family members (but they do describe weakened states after the start of chemotherapy) Not mentioned by all except one Not contacted for any information with regard to health and functional status